Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

The National Institute for Health and Care Excellence (NICE) invited Alimera Sciences, the company manufacturing fluocinolone acetonide intravitreal implant (FAc) 0.19 mg (tradename ILUVIEN(®)), to submit evidence on the clinical and cost-effectiveness of FAc for treating recurrent non-infectious uv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacoeconomics
Main Authors: Pouwels, Xavier G. L. V., Petersohn, Svenja, Carrera, Vanesa Huertas, Denniston, Alastair K., Chalker, Annette, Raatz, Heike, Armstrong, Nigel, Shah, Dhwani, Witlox, Willem, Worthy, Gill, Noake, Caro, Riemsma, Rob, Kleijnen, Jos, Joore, Manuela A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7176320/
https://ncbi.nlm.nih.gov/pubmed/31701471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-019-00851-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados